Generics & Specialities LDA ,vale D Pharmaceutical Import Profile — Mozambique (DGFT 2022–2026)

Name: Generics & Specialities LDA ,vale D Pharmaceutical Import Records from India — 5 Products, $1.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Generics & Specialities LDA ,vale D — Pharmaceutical Importer Profile (2026) | 5 Products, $1.1M Trade | TransData Nexus

Generics & Specialities LDA ,vale D

Pharmaceutical Importer · Mozambique · Antibiotics Focus · $1.1M Total Trade · DGFT Verified

Generics & Specialities LDA ,vale D is a pharmaceutical importer based in Mozambique with a total trade value of $1.1M across 5 products in 3 therapeutic categories. Based on 21 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Generics & Specialities LDA ,vale D sources from 1 verified Indian supplier, with Lincoln Pharmaceuticals Limited accounting for 100.0% of imports.

Generics & Specialities LDA ,vale D — Import Portfolio & Supplier Network

Generics & Specialities LDA ,vale D import network — 5 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Generics & Specialities LDA ,vale D?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Lincoln Pharmaceuticals Limited	$1.1M	30	100.0%

Generics & Specialities LDA ,vale D sources from 1 verified Indian supplier across 9 distinct formulations. The sourcing is highly concentrated — Lincoln Pharmaceuticals Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Erythromycin stearate for oral	$216.6K	6
Nystatin oral suspension USP 100000	$125.2K	3
Acyclovir tablets USP 400 MG	$108.8K	3
Clotrimazole vaginal insert USP 100 MG	$108.6K	3
Diclofenac, linseed oil, menthol with	$105.8K	3
Acyclovir tablets USP 200 MG	$105.0K	3
Ibuprofen oral suspension BP 100MG/5ML	$103.8K	3
Sildenafil citrate tablets (santro-100)	$103.5K	3
Gentamicin eye/ear drops (l?genta)	$102.0K	3

Import Portfolio — Top 5 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Acyclovir	Antivirals	$300.0K	6	0.2%	9
2	Erythromycin	Antibiotics	$300.0K	6	0.4%	3
3	Clotrimazole	Antifungals	$150.0K	3	0.2%	7
4	Gentamicin	Antibiotics	$150.0K	3	0.3%	17
5	Nystatin	Antifungals	$150.0K	3	0.3%	5

Generics & Specialities LDA ,vale D imports 5 pharmaceutical products across 3 categories into Mozambique totaling $1.1M.

Generics & Specialities LDA ,vale D — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Generics & Specialities LDA, established in 1996, is a prominent pharmaceutical importer and distributor based in Maputo, Mozambique. The company operates as a subsidiary of Generics & Specialities Limited, a pharmaceutical and healthcare leader in Africa since 1991, with a presence in multiple African countries, including Angola, Mauritius, Nigeria, and Tanzania. Generics & Specialities LDA plays a pivotal role in Mozambique's pharmaceutical distribution network, ensuring the availability of essential medicines and medical consumables across the country.

2Distribution Network

The company's headquarters are located at Vale do Infulene, Rua de Djamanguane 31.0.21, Machava Municipio de Matola, Maputo, Mozambique. While specific details about their warehouse locations and logistics capabilities are not publicly disclosed, Generics & Specialities LDA is known for its extensive distribution network that reaches over 300 million people across five key African markets. This infrastructure supports the efficient delivery of ethically sourced pharmaceutical products compliant with FDA standards.

3Industry Role

Generics & Specialities LDA serves as a primary wholesaler and distributor in Mozambique's pharmaceutical supply chain. By importing a diverse range of finished pharmaceutical formulations from international suppliers, including India, the company ensures a steady supply of essential medicines to various healthcare providers, including public hospitals, private clinics, and retail pharmacies. Their role is crucial in meeting the country's healthcare needs and maintaining the availability of critical medications.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Generics & Specialities LDA ,vale D

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

The company's import data indicates a significant concentration in sourcing from a single supplier, Lincoln Pharmaceuticals Limited, which accounts for 100% of their pharmaceutical imports from India. This single-source dependency could pose risks related to supply chain disruptions, such as production delays or quality control issues. However, the consistent volume of shipments and the established relationship with Lincoln Pharmaceuticals Limited suggest a stable and reliable partnership. To mitigate potential risks, Generics & Specialities LDA may consider diversifying its supplier base to enhance supply chain resilience.

2Supply Chain Resilience

The resilience of Generics & Specialities LDA's supply chain is closely tied to the stability and reliability of Lincoln Pharmaceuticals Limited. The company's focus on importing finished pharmaceutical formulations from a single supplier may limit its ability to adapt to sudden changes in the supply chain. To strengthen supply chain resilience, Generics & Specialities LDA could explore partnerships with additional suppliers, ensuring a more diversified and robust supply chain. Additionally, evaluating alternative shipping routes and maintaining compliance with international regulatory standards can further enhance supply chain stability.

Strategic Implications

Importing Pharmaceuticals into Mozambique — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Mozambique

1Regulatory Authority & Framework

The pharmaceutical sector in Mozambique is regulated by the Autoridade Nacional Reguladora de Medicamentos de Moçambique (ANARME), established under the Medicines Act of 2017. ANARME is responsible for ensuring the quality, safety, efficacy, and traceability of all pharmaceutical products circulating in the country. Before importation, distribution, or sale, all pharmaceutical products must obtain marketing authorization from ANARME. This regulatory framework aligns with international best practices, ensuring that imported medicines meet the necessary standards for public health.

2Import Licensing & GMP

All importers and exporters in Mozambique must be licensed by the Ministry of Industry and Commerce. Pre-shipment inspections are mandatory for all imports, and special import permits and licenses are required for pharmaceuticals. Importers must ensure that their products comply with Good Manufacturing Practice (GMP) standards recognized by international bodies such as the World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Obtaining these certifications is essential for the legal importation and distribution of pharmaceutical products in Mozambique.

Quality & Labeling

Generics & Specialities LDA ,vale D — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Generics & Specialities LDA's focus on importing antibiotics, antivirals, and antifungals aligns with the prevalent health challenges in Mozambique, where infectious diseases are a significant concern. The demand for these therapeutic areas is driven by the need to combat bacterial, viral, and fungal infections that affect a large portion of the population. By concentrating on these categories, the company addresses critical healthcare needs and contributes to improving public health outcomes in the country.

2Sourcing Profile

The company's sourcing strategy emphasizes importing finished pharmaceutical formulations, particularly from India, which is known for its robust pharmaceutical manufacturing sector. This approach ensures a steady supply of high-quality medicines that meet international standards. By focusing on finished products, Generics & Specialities LDA can efficiently distribute medications without the complexities associated with raw material sourcing and manufacturing.

3Market Positioning

Generics & Specialities LDA serves a broad segment of the Mozambican pharmaceutical market, including retail pharmacies, hospitals, and government tenders. By providing a diverse range of essential medicines, the company ensures that various healthcare providers have access to the necessary pharmaceuticals to meet patient needs. This comprehensive service enhances the company's position as a key player in the country's healthcare supply chain.

Seller's Guide — How to Become a Supplier to Generics & Specialities LDA ,vale D

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Mozambican market by partnering with Generics & Specialities LDA. The company's current sourcing pattern indicates potential gaps in their supplier base, which could be addressed by introducing alternative suppliers offering competitive products. Indian exporters should focus on meeting the quality standards and regulatory requirements of the Mozambican market to effectively penetrate this segment.

2Requirements & Qualifications

Indian exporters aiming to supply Generics & Specialities LDA must ensure that their products comply with ANARME's regulations, including obtaining marketing authorization for each pharmaceutical product. Products should meet GMP standards recognized by international bodies such as WHO and PIC/S. Additionally, labeling must be in Portuguese, and products should undergo necessary quality control measures, including batch testing and stability assessments.

3How to Approach

Frequently Asked Questions — Generics & Specialities LDA ,vale D

What products does Generics & Specialities LDA ,vale D import from India?

Generics & Specialities LDA ,vale D imports 5 pharmaceutical products across 3 categories. Top imports: Acyclovir ($300.0K), Erythromycin ($300.0K), Clotrimazole ($150.0K), Gentamicin ($150.0K), Nystatin ($150.0K).

Who supplies pharmaceuticals to Generics & Specialities LDA ,vale D from India?

Generics & Specialities LDA ,vale D sources from 1 verified Indian suppliers. The primary supplier is Lincoln Pharmaceuticals Limited (100.0% of imports, $1.1M).

What is Generics & Specialities LDA ,vale D's total pharmaceutical import value?

Generics & Specialities LDA ,vale D's total pharmaceutical import value from India is $1.1M, based on 21 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Generics & Specialities LDA ,vale D focus on?

Generics & Specialities LDA ,vale D imports across 3 categories. The largest: Antibiotics (42.9%), Antivirals (28.6%), Antifungals (28.6%).

Get Full Generics & Specialities LDA ,vale D Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.